These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 26468984)

  • 121. Identification of Circulating Biomarker Candidates for Hepatocellular Carcinoma (HCC): An Integrated Prioritization Approach.
    Awan FM; Naz A; Obaid A; Ali A; Ahmad J; Anjum S; Janjua HA
    PLoS One; 2015; 10(9):e0138913. PubMed ID: 26414287
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Identify GADD45G as a potential target of 4-methoxydalbergione in treatment of liver cancer: bioinformatics analysis and in vivo experiment.
    Zeng LP; Qin YQ; Lu XM; Feng ZB; Fang XL
    World J Surg Oncol; 2023 Oct; 21(1):324. PubMed ID: 37833694
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Harnessing the RNA interference pathway to advance treatment and prevention of hepatocellular carcinoma.
    Arbuthnot P; Thompson LJ
    World J Gastroenterol; 2008 Mar; 14(11):1670-81. PubMed ID: 18350598
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Tumour-specific amplitude-modulated radiofrequency electromagnetic fields induce differentiation of hepatocellular carcinoma via targeting Ca
    Jimenez H; Wang M; Zimmerman JW; Pennison MJ; Sharma S; Surratt T; Xu ZX; Brezovich I; Absher D; Myers RM; DeYoung B; Caudell DL; Chen D; Lo HW; Lin HK; Godwin DW; Olivier M; Ghanekar A; Chen K; Miller LD; Gong Y; Capstick M; D'Agostino RB; Munden R; Merle P; Barbault A; Blackstock AW; Bonkovsky HL; Yang GY; Jin G; Liu L; Zhang W; Watabe K; Blackman CF; Pasche BC
    EBioMedicine; 2019 Jun; 44():209-224. PubMed ID: 31160272
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Design and synthesis of doublecortin-like kinase 1 inhibitors and their bioactivity evaluation.
    Pan P; Ji D; Li Z; Meng X
    J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2287990. PubMed ID: 38062554
    [TBL] [Abstract][Full Text] [Related]  

  • 126. MicroRNAs in hepatocellular carcinoma treatment: Charting the path forward.
    Lin HT; Castaneda AFA; Krishna SG; Mumtaz K
    World J Gastroenterol; 2024 Mar; 30(11):1470-1474. PubMed ID: 38617456
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Autoregulatory control of microtubule binding in doublecortin-like kinase 1.
    Agulto RL; Rogers MM; Tan TC; Ramkumar A; Downing AM; Bodin H; Castro J; Nowakowski DW; Ori-McKenney KM
    Elife; 2021 Jul; 10():. PubMed ID: 34310279
    [TBL] [Abstract][Full Text] [Related]  

  • 128. DCLK1 and its oncogenic functions: A promising therapeutic target for cancers.
    Ye L; Liu B; Huang J; Zhao X; Wang Y; Xu Y; Wang S
    Life Sci; 2024 Jan; 336():122294. PubMed ID: 38007147
    [TBL] [Abstract][Full Text] [Related]  

  • 129. The Role of Small Interfering RNAs in Hepatocellular Carcinoma.
    Chen F; Zhang W; Gao X; Yuan H; Liu K
    J Gastrointest Cancer; 2024 Mar; 55(1):26-40. PubMed ID: 37432548
    [TBL] [Abstract][Full Text] [Related]  

  • 130. DCLK1 phosphorylates the microtubule-associated protein MAP7D1 to promote axon elongation in cortical neurons.
    Koizumi H; Fujioka H; Togashi K; Thompson J; Yates JR; Gleeson JG; Emoto K
    Dev Neurobiol; 2017 Apr; 77(4):493-510. PubMed ID: 27503845
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Discovery of a doublecortin-like kinase 1 inhibitor to prevent inflammatory responses in acute lung injury.
    Cai B; Xu Y; Luo R; Lu K; Wang Y; Zheng L; Zhang Y; Yin L; Tu L; Luo W; Zheng L; Zhang F; Lv X; Tang Q; Liang G; Chen L
    Bioorg Chem; 2024 Apr; 145():107215. PubMed ID: 38394920
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Identification of ABCC3 and its isoforms as potential biomarker in hepatocellular carcinoma.
    Zertuche-Martínez C; Velázquez-Enríquez JM; González-García K; Baltiérrez-Hoyos R; Carrasco-Torres G; García-Román R; Romero-Díaz RI; Pérez-Hernández JL; Muriel P; Villa-Treviño S; Arellanes-Robledo J; Vásquez-Garzón VR
    Toxicol Mech Methods; 2024 May; 34(4):398-407. PubMed ID: 38083799
    [TBL] [Abstract][Full Text] [Related]  

  • 133. The challenges and potential of microRNA-based therapy for patients with liver failure syndromes and hepatocellular carcinoma.
    Tavabie OD; Salehi S; Aluvihare VR
    Expert Opin Ther Targets; 2024 Mar; 28(3):179-191. PubMed ID: 38487923
    [TBL] [Abstract][Full Text] [Related]  

  • 134. MicroRNAs as the critical regulators of tumor angiogenesis in liver cancer.
    Fanoodi A; Maharati A; Akhlaghipour I; Rahimi HR; Moghbeli M
    Pathol Res Pract; 2023 Nov; 251():154913. PubMed ID: 37931431
    [TBL] [Abstract][Full Text] [Related]  

  • 135. MicroRNA-495: a therapeutic and diagnostic tumor marker.
    Maharati A; Tolue Ghasaban F; Akhlaghipour I; Taghehchian N; Zangouei AS; Moghbeli M
    J Mol Histol; 2023 Dec; 54(6):559-578. PubMed ID: 37759132
    [TBL] [Abstract][Full Text] [Related]  

  • 136. Profiling the circulating mRNA transcriptome in human liver disease.
    Sayeed A; Dalvano BE; Kaplan DE; Viswanathan U; Kulp J; Janneh AH; Hwang LY; Ertel A; Doria C; Block T
    Oncotarget; 2020 Jun; 11(23):2216-2232. PubMed ID: 32577166
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Dclk1 Defines Quiescent Pancreatic Progenitors that Promote Injury-Induced Regeneration and Tumorigenesis.
    Westphalen CB; Takemoto Y; Tanaka T; Macchini M; Jiang Z; Renz BW; Chen X; Ormanns S; Nagar K; Tailor Y; May R; Cho Y; Asfaha S; Worthley DL; Hayakawa Y; Urbanska AM; Quante M; Reichert M; Broyde J; Subramaniam PS; Remotti H; Su GH; Rustgi AK; Friedman RA; Honig B; Califano A; Houchen CW; Olive KP; Wang TC
    Cell Stem Cell; 2016 Apr; 18(4):441-55. PubMed ID: 27058937
    [TBL] [Abstract][Full Text] [Related]  

  • 138. Dominant Expression of DCLK1 in Human Pancreatic Cancer Stem Cells Accelerates Tumor Invasion and Metastasis.
    Ito H; Tanaka S; Akiyama Y; Shimada S; Adikrisna R; Matsumura S; Aihara A; Mitsunori Y; Ban D; Ochiai T; Kudo A; Arii S; Yamaoka S; Tanabe M
    PLoS One; 2016; 11(1):e0146564. PubMed ID: 26764906
    [TBL] [Abstract][Full Text] [Related]  

  • 139. Doublecortin-like kinase 1 expression associates with breast cancer with neuroendocrine differentiation.
    Liu YH; Tsang JY; Ni YB; Hlaing T; Chan SK; Chan KF; Ko CW; Mujtaba SS; Tse GM
    Oncotarget; 2016 Jan; 7(2):1464-76. PubMed ID: 26621833
    [TBL] [Abstract][Full Text] [Related]  

  • 140. Doublecortin and CaM kinase-like-1 as an independent prognostic factor in patients with resected pancreatic carcinoma.
    Nishio K; Kimura K; Amano R; Nakata B; Yamazoe S; Ohira G; Miura K; Kametani N; Tanaka H; Muguruma K; Hirakawa K; Ohira M
    World J Gastroenterol; 2017 Aug; 23(31):5764-5772. PubMed ID: 28883702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.